文献速递瓣膜外科

全州质量改进项目推动主动脉瓣环扩大术的应用

A Statewide Quality Initiative to Promote Aortic Annular Enlargement: Leading an Evolving Paradigm Shift.
PubMed 文献 · Ann Thorac Surg · 2025-09-13

结果显示干预后AVR+AAE比例由7%升至19%,人工瓣膜中位尺寸由23 mm增至25 mm,Y形切口技术采用率由20%升至70%,30天死亡率、输血及并发症无显著差异。

要点

  • 质量改进干预后AVR+AAE比例由7%升至19%,孤立AVR+AAE由8%升至23%
  • 人工瓣膜中位尺寸由23 mm增至25 mm,Y形切口采用率由20%升至70%
  • 30天死亡率、输血及并发症无显著差异

核心结论

  • 全州质量改进干预提升了AVR术中AAE的采用率,使植入更大尺寸的主动脉瓣假体,且未显著增加并发症或死亡率。

主要发现

  • 干预后AVR+AAE发生率由7%升至19%(P < .001),孤立AVR+AAE病例由8%升至23%(P < .001)。
  • 人工瓣膜中位尺寸由23 mm增至25 mm(P < .001)。
  • Y形切口技术采用率由20%升至70%(P < .001),实施该技术的外科医生由18名增至35名。
  • 30天死亡率、输血及并发症等次要终点无显著差异,敏感性分析结果一致。

临床怎么用

  • 可通过湿实验室培训等质量改进干预推动AAE及Y形切口技术开展,在AVR中植入更大尺寸瓣膜以预防患者-假体不匹配。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Aortic annular enlargement (AAE) represents an important adjunct strategy during aortic valve replacement (AVR), enabling implantation of a larger prosthesis to prevent patient-prosthesis mismatch. This study evaluated the results of a statewide quality improvement intervention (QII) to increase AAE adoption, including the novel Y-incision technique. METHODS: Using The Society of Thoracic Surgeons database, we identified patients undergoing AVR with or without AAE from January 2018 to December 2023, excluding emergent and endocarditis cases. A QII was initiated in September 2021 and again in May 2023 featuring wet laboratory training in AAE techniques. Patients were assigned to pre-QII (before September 2021) and post-QII groups. Primary end points were AVR+AAE incidence and median prosthesis size; secondary end points included 30-day mortality, transfusions, and morbidity. Sensitivity analyses were performed on isolated AVR+AAE cases. RESULTS: A total of 817 patients were included (pre-QII, 330; post-QII, 487), and 11.6% of the audited operative notes were reassigned to the QII Y-incision subgroup. Post-QII patients showed increased AVR+AAE incidence (7% vs 19%; P < .001), with isolated AVR+AAE cases rising from 8% to 23% (P < .001). Median prosthesis size increased from 23 to 25 mm (P < .001). Y-incision adoption rose significantly (20% vs 70%; P < .001), with more surgeons implementing the technique in the post-QII group (18 vs 35). No significant differences were observed in secondary end points. Sensitivity analyses confirmed findings. CONCLUSIONS: A pilot QII enhanced AAE adoption during AVR, leading to a larger aortic valve prosthesis without a significant increase in morbidity or mortality. Future research should explore midterm and long-term benefits on patient outcomes, including quality of life and survival.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Magouliotis DE, Topcu AC, Estrada Mendoza RM, et al. A Statewide Quality Initiative to Promote Aortic Annular Enlargement: Leading an Evolving Paradigm Shift. Ann Thorac Surg. 2025. PMID: 40953788. doi:10.1016/j.athoracsur.2025.08.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。